Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-04

Clinical Trial Update: Treating Nocturnal Hypertension and Nocturia in African American Men [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating treatment of nocturnal hypertension and nocturia in African American men has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: High Blood Pressure | Phase 4 | Status: WITHDRAWN